Published in Vestn Dermatol Venerol on August 01, 1974
[The antiradical activity of coumarin reductones]. Biull Eksp Biol Med (1991) 0.76
[The effect of mexidol on the development of experimental peroxide athero-arteriosclerosis]. Eksp Klin Farmakol (1993) 0.75
[Effects of antioxidant emoxipin on lipid metabolism in the lungs during development of pulmonary edema]. Biull Eksp Biol Med (1992) 0.75
[The effect of 3-hydroxypyridine derivatives on postischemic disorders in the autoregulatory reactions of the cerebral vessels]. Eksp Klin Farmakol (1997) 0.75
[Interaction of nonelectrolytes, the derivatives of 5-hydroxybenzimidazole, with erythrocyte membrane]. Biofizika (2005) 0.75
[Angioprotective activity of mexicor in atherosclerosis obliterans of the lower limbs]. Angiol Sosud Khir (2007) 0.75
[Effect of subchronic administration of phenazepam and synthetic antioxidants on the functional status of synaptic membranes in the cerebral cortex of rats subjected to prolonged stress]. Biull Eksp Biol Med (1988) 0.75
[Experimental increase in lifespan due to the action of 2-ethyl-6-methyl-3-hydroxypyridine chlorhydrate]. Dokl Akad Nauk SSSR (1976) 0.75
[Is trimetazidine an antioxidant?]. Biull Eksp Biol Med (1998) 0.75
[Effectiveness of peloidotherapy in patients with some chronic dermatoses at the Saki resort]. Vestn Dermatol Venerol (1971) 0.75
[The specific lymphocytolysis reaction in syphilis patients]. Vestn Dermatol Venerol (1988) 0.75
[The bioavailability of tableted drug forms of the new Russian nootropic preparation nooglutil in rabbits]. Eksp Klin Farmakol (1998) 0.75
[Structure of dermatological morbidity along the Mediterranean coast]. Vestn Dermatol Venerol (1987) 0.75
Experimental analysis of the mechanisms of ageing in Drosophila melanogaster. Exp Gerontol (1979) 0.75
[3-Hydroxypyridine derivatives--a new class of psychotropic compounds]. Vestn Akad Med Nauk SSSR (1984) 0.75
[Case of sudden gangrene of the penis]. Vestn Dermatol Venerol (1973) 0.75
[Inhibition of cyclic nucleotide phosphodiesterase from the rod outer segments of the frog retina by 3-hydroxypyridine]. Nauchnye Doki Vyss Shkoly Biol Nauki (1984) 0.75
Influence of the geroprotector 2-ethyl-6-methyl-3-hydroxypyridine hydrochloride on the lifetime of Drosophila melanogaster. Biol Bull Acad Sci USSR (1979) 0.75
[Relationship between the chemical structure and anticonvulsant activity of 3-hydroxypyridine derivatives]. Farmakol Toksikol (1987) 0.75
[Late results of mud treatment in patients with chronic dermatoses at the Saki resort]. Vestn Dermatol Venerol (1977) 0.75
A new molecular aspect in 6-methyl-2-ethyl-3-oxypyridine (6M2E3OP) membrane-associated geroprotective action. Exp Pathol (1987) 0.75
[Antiradical and NO-inhibiting activities of bet-hydroxy(ethoxy) derivatives of nitrous heterocycles]. Biofizika (2011) 0.75
[The possible participation of brain peptidases in regulating the memory function during aging]. Dokl Akad Nauk SSSR (1991) 0.75
[Effect of mud therapy on certain indices of the functional state of the skin and of allergic reactivity in chronic dermatoses]. Vestn Dermatol Venerol (1974) 0.75
[Effect of antioxidants on the synthesis of prostaglandins, prostacyclin and thromboxane in different layers of the kidneys of old rats]. Farmakol Toksikol (1986) 0.75
[Inhibition of thrombocyte aggregation by antioxidants]. Biull Eksp Biol Med (1986) 0.75
[Immunotropic activity of new hydroxypyrimidine derivatives]. Farmakol Toksikol (1979) 0.75
[Current trends in the search for membrane-active compounds and membrane-active compound-based drugs]. Vestn Akad Med Nauk SSSR (1984) 0.75
[Slowing of the aging process in laboratory mice exposed to 2-ethyl-6-methyl-3-hydroxypyridine hydrochloride]. Izv Akad Nauk SSSR Biol (1977) 0.75
[Changes in the cyclic nucleotide level and the inhibition of human thrombocyte aggregation in 3-hydroxypyridine exposure]. Biull Eksp Biol Med (1986) 0.75
[Mexidol effects in extreme conditions (experiments with animals)]. Aviakosm Ekolog Med (2008) 0.75
[Effect of hydroxymethylethylpyridine succinate on the cardiac electrophysiological and hemodynamic parameters during experimental thoracotomy and acute myocardial ischemia]. Eksp Klin Farmakol (2004) 0.75
[Effect of age on the kinetics of the development of spontaneous and transplantable tumors and on chemotherapy effectiveness]. Izv Akad Nauk SSSR Biol (1984) 0.75
[Synthetic antioxidant correction for disorders of the regulatory and microcirculatory systems in the early stages of experimental atherosclerosis]. Biull Eksp Biol Med (1993) 0.75
[Pharmacokinetics of a water-soluble antioxidant from the class of 3-hydroxypyridines]. Biull Eksp Biol Med (1986) 0.75
[Effect of different substances on the x-ray chemiluminescence of solutions of serum albumin and glycyltryptophan]. Biofizika (1980) 0.75
[Antioxidants--stabilizers of the Ca2+ transport enzyme system in sarcoplasmic reticulum membranes in vivo]. Biull Eksp Biol Med (1986) 0.75
[Antibody content in different immunoglobulin classes in syphilis]. Vestn Dermatol Venerol (1980) 0.75
[Effect of alkyl-substituted beta-oxy derivatives of pyridine on erythrocyte acetylcholinesterase activity]. Izv Akad Nauk SSSR Biol (1983) 0.75
[Antistressor and analgesic effects of mexidol, diazepam, paracetamol, and their combinations]. Eksp Klin Farmakol (2006) 0.75
Antioxidative activity of lipids in mice during aging and administration of an antioxidant with gerontological protective action. Biol Bull Acad Sci USSR (1980) 0.75
[Antioxidant activity of lipids during aging in mice and after exposure to an antioxidant geroprotector]. Izv Akad Nauk SSSR Biol (1979) 0.75
[Possible pharmacological correction of metabolic impairments experimental diabetes mellitus by antioxidant]. Biomed Khim (2005) 0.75
[Antiradical activity of complex copper compounds (II) on coumarin ligand base]. Biull Eksp Biol Med (1992) 0.75
[Effect of antioxidants of the 3-hydroxypyridine class on cyclic 3', 5'-adenosine monophosphate phosphodiesterase activity]. Biull Eksp Biol Med (1983) 0.75
[Geropsychotropic properties of an antioxidant of the 3-hydroxypyridine class in an experiment]. Biull Eksp Biol Med (1986) 0.75
[Effect of free-radical process inhibitors on dark-and light-induced e.p.r. signals in melanoprotein granules of the eye pigment epithelium]. Dokl Akad Nauk SSSR (1976) 0.75
[Structural-functional changes in biomembranes during complications of diabetes mellitus and their pharmacological correction]. Vopr Med Khim (2000) 0.75
[Protection of blood cells from hypotonic hemolysis and mechanical damage with 3-hydroxypyridine derivatives]. Izv Akad Nauk SSSR Biol (1979) 0.75
[Bacterioscopic diagnosis of active forms of syphilis]. Vestn Dermatol Venerol (1970) 0.75
[The anti-ischemic effects of 3-hydroxypyridine derivatives in cerebrovascular pathology]. Eksp Klin Farmakol (1999) 0.75
[Enhancement of erythrocyte hemolytic resistance by derivatives of nitrogenous heterocycles]. Izv Akad Nauk SSSR Biol (1987) 0.75
[Effect of the geroprotector 2-ethyl-6-methyl-3-hydroxypyridine on zinc, copper, and iron concentration in mouse tissues]. Izv Akad Nauk SSSR Biol (1980) 0.75
[Stabilizing effect of hydroxybenzimidazole and its derivatives on biological membranes during activation of lipid peroxidation]. Biull Eksp Biol Med (1987) 0.75
[Histological and cytological studies in gonorrheal endocervicitis]. Akush Ginekol (Mosk) (1981) 0.75
[Effect of a membrane modulator from the 3-hydroxypyridine class on the pharmacological activity of a number of psychotropic preparations]. Biull Eksp Biol Med (1985) 0.75
[The mutagenic and modifying properties of emoxipin studied by micronucleus assay in liver cells]. Izv Akad Nauk Ser Biol (1996) 0.75
Protection of blood cells by derivatives of 3-hydroxypyridine under conditions of hypotonic hemolysis and during mechanical trauma. Biol Bull Acad Sci USSR (1980) 0.75
[The hormone-metabolic changes in the diabetic angiopathy]. Vopr Med Khim (1998) 0.75
[Effect of inhibitor-antioxidant of 3-hydroxypyridine series on cellular immunity]. Biull Eksp Biol Med (1982) 0.75
[Correction of physical performance of mice with the derivatives of 3-oxypyridine and pyridine]. Aviakosm Ekolog Med (2002) 0.75
[Dynamics of morphohistochemical indicators of the skin in psoriasis, eczema and neurodermatitis during mud therapy]. Vestn Dermatol Venerol (1976) 0.75
[Effect of mexidol on the level of monoamine mediators and amino acids in rat brain structures]. Biull Eksp Biol Med (1996) 0.75
[Inhibition of cyclic nucleotide phosphodiesterase from rabbit heart by hydroxypyridines]. Vopr Med Khim (1983) 0.75
[Lipid reducing and antioxidant action of mexicor in patients with diabetes mellitus type 2]. Ter Arkh (2006) 0.75
[Effect of an antioxidant on the recovery of hematopoiesis and thrombocyte aggregation]. Izv Akad Nauk SSSR Biol (1983) 0.75
[Effect of 3-hydroxypyridine derivatives on the central nervous system]. Biull Eksp Biol Med (1985) 0.75
[Effect of antioxidants on the proliferation of human diploid cells at various phases of the culture growth]. Tsitologiia (1988) 0.75
[The role of GABA-benzodiazepine receptor complex in affecting the anxiolytic effect of 3-hydroxypyridines--new non-benzodiazepine tranquilizers]. Biull Eksp Biol Med (1986) 0.75
[Pelotherapy of psoriatic arthritis]. Vestn Dermatol Venerol (1977) 0.75
[A new substance with nootropic activity--N-5(hydroxynicotinoyl)-L-glutamic acid]. Farmakol Toksikol (1990) 0.75
[Role of the GABA- and cholinergic systems in the formation of a dissociated state to an antioxidant of the 3-hydroxypyridine class]. Biull Eksp Biol Med (1987) 0.75
[Interaction with cytochrome P-450 as one of the mechanisms of protective action of 3-hydroxypyridines in the diethylnitrosamine poisoning of animals]. Izv Akad Nauk SSSR Biol (1985) 0.75
[Relationship of tumor necrosis factor alpha expression with activation of sphingomyelinase and lipid peroxidation after removal of cholestatic factor]. Izv Akad Nauk Ser Biol (2007) 0.75
[Dermatitis due to Euphorbia rigida M.B]. Vestn Dermatol Venerol (1970) 0.75
[Effects of a membrane modulator derived from 3-hydroxypyridine class on the development of pulmonary edema]. Biull Eksp Biol Med (1990) 0.75
[Combined administration of mexidol and anti-arrhythmia agents]. Eksp Klin Farmakol (2003) 0.75
[Nonspecific immunotherapy using 2,4,6-trimethylhydroxypyrimidine (OPM-111) in Mycoplasma arthritidis infection in mice]. Antibiot Med Biotekhnol (1986) 0.75
[Effect of 3-oxypyridine derivatives on the blood cell resistance to mechanical trauma]. Patol Fiziol Eksp Ter (1979) 0.75
[Leukocyte agglomeration reaction in chronic endocervicites in female gonorrhea carriers]. Vestn Dermatol Venerol (1980) 0.75
[Investigation of the anti-motion sickness effect of 3-hydroxypyridine derivatives]. Aviakosm Ekolog Med (2005) 0.75
[Balneoreactions in mud therapy of patients with chronic dermatoses]. Vestn Dermatol Venerol (1976) 0.75
[Effect of mexidol and its structural components on carbohydrate level and lipid peroxidation in acute stress]. Vopr Med Khim (1999) 0.75
[Effect of the geroprotector 2-ethyl-6-methyl-3-hydroxypyridine chlorhydrate on the life span of Drosophila melanogaster]. Izv Akad Nauk SSSR Biol (1978) 0.75
[Effect of inhibitors of free radical processes on the "dark" paramagnetic centers of the melanoprotein granules of the pigment epithelium of the eye]. Biofizika (1979) 0.75
[Inhibition of platelet aggregation and cyclic nucleotide phosphodiesterase (specifically cyclAMP) by 3-hydroxypyridine derivatives]. Biull Eksp Biol Med (1984) 0.75
[Correction by 2-ethyl-6-methyl-3-hydroxypyridine succinate of the hepatotoxyc, caused at rats introduction tuberculostatics]. Biomed Khim (2004) 0.75
[Effect of the inhibitor-antioxidant belonging to the 3-hydroxypyridine series on immunocompetent and stem cells]. Biull Eksp Biol Med (1980) 0.75
[Electrophysiological and biochemical mechanisms of the anticonvulsant action of an antioxidant of the 3-hydroxypyridine class]. Biull Eksp Biol Med (1986) 0.75
[Metabolism of an antioxidant of the 3-hydroxypyridine class]. Farmakol Toksikol (1988) 0.75
[Antioxidant probucol prevents development of alloxan diabetes and decrease of antioxidant enzyme activity in rat tissues]. Biull Eksp Biol Med (1992) 0.75
Studying the photoprotective activity of a new class of heteroaromatic antioxidants. Bull Exp Biol Med (2009) 0.75